Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 70518-4769

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 70518-4769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure of quetiapine, the active ingredient in Quetiapine Extended Release 300 mg tablets by REMEDYREPACK INC. The diagram shows the molecular structure including two quetiapine moieties and one counter ion depicted.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A line graph showing the proportion of patients with relapse (%) over time (months). Two lines are compared: one for PLA and one for QTP XR, with the QTP XR line generally showing a lower relapse proportion throughout the 7-month period.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A line graph depicting the proportion of patients with relapse (%) over time (weeks) comparing two treatment groups, labeled as 'CTP + LIVAL' and 'PLA + LIVAL'. The x-axis represents time up to 100 weeks, and the y-axis shows the proportion of patients with relapse, ranging from 0 to 100%. The graph shows distinct curves for the two groups with relapse rates increasing over time.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A Kaplan-Meier curve graph showing the proportion of patients with relapse over time in weeks. The graph compares two groups labeled as QTP + LIVAL and PLA + LIVAL, illustrating differences in relapse rates across approximately 100 weeks.*

FDA Label Image

Remedy_label (Remedy Label)

Label for Quetiapine Extended Release 300 mg oral tablets, film coated, with a quantity of 30 tablets. The label includes storage instructions, manufacturer info (ScieGen, Hauppauge, NY), and repackager details (RemedyRepack Inc., Indiana, PA). The NDC 70518-4769-00 is displayed along with medication handling warnings and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.